Fny Investment Advisers, LLC Geron Corp Transaction History

Fny Investment Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 10, 2023	BUY	$2.03 - $2.42 $18,069 - $21,540	8,901 New	8,901 $21,000
Q2 2021 Jul 14, 2021	SELL	$1.25 - $1.83 $19,683 - $28,817	-15,747 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$1.52 - $2.1 $124,264 - $171,681	-81,753 Reduced 83.85%	15,747 $24,000
Q4 2020 Jan 19, 2021	BUY	$1.55 - $2.05 $136,651 - $180,732	88,162 Added 944.12%	97,500 $155,000
Q4 2018 Jan 22, 2019	BUY	$0.98 - $1.85 $9,151 - $17,275	9,338 New	9,338 $9,000

259

450M

1.91M

897K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.59B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.